5-alpha reductase inhibitors (Aventis)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Name5-alpha reductase inhibitors (Aventis)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSteroid 5 alpha reductase inhibitors

TargetsSteroid 5 alpha reductase

Therapy Area/IndicationsProstatic Hyperplasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis Pharma

Active IndicationsN/A

Inactive IndicationsProstatic Hyperplasia

ATC CodeN/A